LADENBURG THALMANN FINANCIAL SERVICES INC. - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 2 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$2,000
+100.0%
3000.0%0.00%
Q3 2019$1,0000.0%3000.0%0.00%
Q2 2019$1,0000.0%3000.0%0.00%
Q1 2019$1,0003000.0%0.00%
Q4 2018$0
-100.0%
3000.0%0.00%
Q3 2018$1,000
-90.9%
300
-89.6%
0.00%
Q2 2018$11,0000.0%2,8790.0%0.00%
Q1 2018$11,000
+22.2%
2,879
-12.2%
0.00%
Q4 2017$9,0000.0%3,279
+57.7%
0.00%
Q3 2017$9,000
-25.0%
2,079
-19.4%
0.00%
Q2 2017$12,000
-70.0%
2,579
-72.8%
0.00%
-100.0%
Q1 2017$40,0009,479
+11898.7%
0.00%
Q4 2016$0
-100.0%
79
-55.9%
0.00%
Q3 2016$2,0000.0%1790.0%0.00%
Q2 2016$2,000
-92.0%
179
-94.3%
0.00%
Q1 2016$25,000
-56.1%
3,154
-40.0%
0.00%
-100.0%
Q4 2015$57,000
-42.4%
5,254
-63.3%
0.00%
-50.0%
Q3 2015$99,000
-22.0%
14,3120.0%0.00%0.0%
Q2 2015$127,000
-9.9%
14,3120.0%0.00%
-33.3%
Q1 2015$141,000
-19.4%
14,3120.0%0.00%
-25.0%
Q4 2014$175,000
+19.0%
14,312
-3.1%
0.00%0.0%
Q3 2014$147,000
+25.6%
14,772
-4.8%
0.00%
+33.3%
Q2 2014$117,000
+28.6%
15,512
-44.0%
0.00%0.0%
Q1 2014$91,000
+82.0%
27,700
+84.7%
0.00%
+50.0%
Q4 2013$50,000
+525.0%
15,000
+500.0%
0.00%
Q3 2013$8,000
-60.0%
2,5000.0%0.00%
-100.0%
Q2 2013$20,0002,5000.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$56,305,0007.98%
BVF INC/IL 2,423,300$10,008,0002.01%
EMORY UNIVERSITY 454,102$1,875,0001.85%
DAFNA Capital Management LLC 196,500$812,0000.71%
Orbimed Advisors 13,107,200$54,133,0000.69%
RTW INVESTMENTS, LP 286,285$1,182,0000.44%
Marcus Capital, LLC 100,000$413,0000.44%
Rock Springs Capital Management LP 1,375,000$5,679,0000.38%
Spark Investment Management LLC 978,600$4,041,0000.33%
Bellevue Group AG 240,000$991,0000.20%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders